Cell signaling of angiotensin II on vascular tone: Novel mechanisms

Current Hypertension Reports

Volumn 13, Issue 2, 2011, Pages 122-128

  Cat, Aurelie Nguyen Dinh ^a   Touyz, Rhian M ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Arachidonic acid metabolites; Renin angiotensin system; RhoA; TRP channels; Vasoconstriction; Vasodilation

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN II; ANKYRIN TRANSMEMBRANE PROTEIN 1; ARACHIDONIC ACID; CALCIUM ION; DIHYDROXYICOSATETRAENOIC ACID; EPOXYICOSATETRAENOIC ACID; HYDROGEN PEROXIDE; HYDROXYICOSATETRAENOIC ACID; MAGNESIUM ION; MEMBRANE PROTEIN; POLYCYSTIN 2; REACTIVE OXYGEN METABOLITE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4;

BLOOD VESSEL TONE; CALCIUM TRANSPORT; CELL FUNCTION; HUMAN; HYPERTENSION; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II; HUMANS; HYDROGEN PEROXIDE; SIGNAL TRANSDUCTION; VASOMOTOR SYSTEM;

EID: 79955963694     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-011-0187-x     Document Type: Review

References (49)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-72.
2. Mehta PK, Griendling KK. Angiotensin II cell signalling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-97.
3. Lemarié CA, Schiffrin EL. The angiotensin II type 2 receptor in cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2010;11(1):19-31.
4. Higuchi S, Ohtsu H, Suzuki H, et al. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2007;112:417-28. (Pubitemid 46587457)
5. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol. 2009;302(2):148-58. This is a comprehensive review on Ang II signaling through NADPH oxidase activation.
6. Di A, Malik AB. TRP channels and the control of vascular function. Curr Opin Pharmacol. 2010;10(2):127-32.
7. Earley S, Brayden JE. Transient receptors potential channels and vascular function. Clin Sci (Lond). 2010;119(1):19-36.
8. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247-57.
9. Berridge MJ. Smooth muscle cell calcium activation mechanisms. J Physiol. 2008;586(Pt 21):5047-61.
10. Touyz RM, El Mabrouk M, He G. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res. 1999;84(5):505-15.
11. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res. 2006;98:322-34.
12. Loirand G, Pacaud P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol. 2010;7(11):637-47.
13. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389(6654):990-4. (Pubitemid 27485693)
14. Seko T, Ito M, Kureishi Y, et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res. 2003;92:411-8. (Pubitemid 36298201)
15. Gohla A, Schultz G, Offermanns S. Role for G12/G13 in agonist-induced vascular smooth muscle cell contraction. Circ Res. 2000;87:221-7. (Pubitemid 30626430)
16. Guilluy C, Bregeon J, Toumaniantz G, et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med. 2010;16:183-90.
17. Wirth A, Benyó Z, Lukasova M, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt induced hypertension. Nat Med. 2008;14:64-8.
18. Bregeon J, Loirand G, Pacaud P, et al. Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2009;297(5):C1062-70.
19. Mori K, Amano M, Takefuji M, et al. Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP. J Biol Chem. 2009;284:5067-76.
20. Tabet F, Schiffrin EL, Callera GE, et al. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res 2008;103 (2):149-58. This study shows that Ang II regulates SHP2 through redox-sensitive processes that influence SHP2 oxidation and phosphorylation.
21. Guilluy C, Rolli-Derkinderen M, Loufrani L, et al. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II type2 receptor activation. Circ Res 2008;102(10):1265-74. This study elucidates novel mechanisms whereby RhoA is regulated by Ang II.
22. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium. 2005;38:233-52. (Pubitemid 41283262)
23. Inoue R, Jensen LJ, Shi J, et al. Transient receptor potential channels in cardiovascular function and disease. Circ Res. 2006;99:119-31. (Pubitemid 44297035)
24. Freichel M, Suh SH, Pfeifer A, et al. Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice. Nat Cell Biol. 2001;3:121-7. (Pubitemid 32118364)
25. Brayden JE, Earley S, Nelson MT, et al. Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow. Clin Exp Pharmacol Physiol. 2008;35(9):1116-20.
26. Mederos y Schnitzler M, Storch U, Meibers S, et al. Go-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J. 2008;27:3092-103.
27. Satoh S, Tanaka H, Ueda Y, Oyama J, Sugano M, Sumimoto H, et al. Transient receptor potential (TRP) protein 7 acts as a G protein-activated Ca2+ channel mediating angiotensin II-induced myocardial apoptosis. Mol Cell Biochem. 2007;294:205-15. (Pubitemid 46188902)
28. 1R, TRPV4, and β-arrestin 1 form a functional complex that may regulate vascular contraction.
29. Touyz RM, He Y, Montezano AC, et al. Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2006;290:R73-8.
30. He Y, Yao G, Savoia C, et al. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res. 2005;96:207-15. (Pubitemid 40209368)
31. Inoue K, Xiong ZG. Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway. Cardiovasc Res 2009;83:547-57. This study highlights the importance of TRPM7 in the regulation of endothelial cell function.
32. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res. 2004;95:922-9. (Pubitemid 39435007)
33. Gonzales AL, Garcia ZI, Amberg GC et al. Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle. Am J Physiol Cell Physiol 2010;299(5):C1195-202. This study demonstrates that TRPM4 is an important regulator of smooth muscle cell membrane depolarization and arterial constriction in response to changes in intraluminal pressure.
34. Mathar I, Vennekens R, Meissner M, et al. Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest. 2010;120(9):3267-79.
35. Lucchesi PA, Belmadani S,Matrougui K. Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfusedmouse mesenteric resistance arteries. J Hypertens. 2005;23(3):571-9. (Pubitemid 40684716)
36. Montezano AC, Burger D, Ceravolo GS, Yusuf H, Montero M, Touyz RM. Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. Clin Sci (Lond). 2011;120(4):131-41.
37. Suvorava T, Lauer N, Kumpf S, et al. Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation. 2005;112(16):2487- 95. 18.
38. Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med. 2006;231:237-51. (Pubitemid 43334308)
39. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal. 2005;7(9-10):1302.
40. 2+ and ROS in Ang II-mediated vasoconstriction.
41. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol Res. 2004;49(6):543-9. (Pubitemid 38338664)
42. Matoba T, Shimokawa H, Nakashima M, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000;106:1521-30. (Pubitemid 32040953)
43. Miura H, Bosnjak JJ, Ning G, et al. Role of hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res. 2003;92:e31-40.
44. Kaneshiro T, Saitoh S, Machii H, et al. Metabolic regulation of coronary vascular tone: role of hydrogen peroxide, purinergic components, and angiotensin. Eur J Pharmacol 2010;645:127-34. This comprehensive review discusses the role of reactive oxygen species and Ang II in the regulation of vascular tone.
45. Campbell WB, Falck JR. Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension. 2007;49:590-6.
46. Williams JM,Murphy S, Burke M, et al. 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. J Cardiovasc Pharmacol. 2010;56(4):336-44.
47. Yaghini FA, Song CY, Lavrentyev EN, et al. Ghafoor HU, Fang XR, Estes AM, Campbell WB, Malik KU. Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation. Hypertension 2010;55(6):1461-7. This study demonstrates that Ang II regulates vascular smooth muscle cell function through arachidonic acid metabolites that signal through redox-sensitive pathways.
48. Michaelis UR, Fleming I. Fromendothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther. 2006;111:584-95. (Pubitemid 44160519)
49. Campbell WB, Fleming I. Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch 2010;459 (6):881-95. This excellent review highlights mechanisms whereby EETs and HETEs modulate vascular tone through effects on endothelial function.